Journal Profile | |||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Journal Title | Nucleic Acid Therapeutics | ||||||||||||||||||||||||||||||||
Journal Title Abbreviations | NUCLEIC ACID THER | ||||||||||||||||||||||||||||||||
ISSN | 2159-3337 | ||||||||||||||||||||||||||||||||
E-ISSN | 2159-3345 | ||||||||||||||||||||||||||||||||
h-index | 61 | ||||||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||||||
Self-Citation Ratio (2020-2021) | 4.90% | ||||||||||||||||||||||||||||||||
期刊简介 | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. | ||||||||||||||||||||||||||||||||
Official Website | http://www.liebertpub.com/nat | ||||||||||||||||||||||||||||||||
Online Manuscript Submission | http://mc.manuscriptcentral.com/nucleicacidtherapeut | ||||||||||||||||||||||||||||||||
Open Access | No | ||||||||||||||||||||||||||||||||
Publisher | 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801 | ||||||||||||||||||||||||||||||||
Subject Area | BIOCHEMISTRY & MOLECULAR BIOLOGY | ||||||||||||||||||||||||||||||||
Country/Area of Publication | UNITED STATES | ||||||||||||||||||||||||||||||||
Publication Frequency | |||||||||||||||||||||||||||||||||
Year Publication Started | 2011 | ||||||||||||||||||||||||||||||||
Annual Article Volume | 23 | ||||||||||||||||||||||||||||||||
Gold OA文章占比 | |||||||||||||||||||||||||||||||||
OA期刊相关信息 | |||||||||||||||||||||||||||||||||
WOS期刊SCI分区 | |||||||||||||||||||||||||||||||||
Indexing (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||||||||||
Link to PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2159-3337%5BISSN%5D | ||||||||||||||||||||||||||||||||
Average Duration of Peer Review * | Authorized Data from Publisher: Data from Authors: >12 Week(s), or Invited contributions | ||||||||||||||||||||||||||||||||
Competitiveness * | Data from Authors: Easy | ||||||||||||||||||||||||||||||||
Useful Links |
| ||||||||||||||||||||||||||||||||
*All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts. As such they may not reflect the journals' exact competitiveness or speed. |
|
|
|
First Previous 1 Next Last (To Page | |
Reviews on Nucleic Acid Therapeutics: | Write a review |
Author: 维尔娜菲茨杰拉德 Subject Area: Medicine Duration of Peer Review: 0.0 month(s) Result: Pending & Unknown Write a review |
Reviewed 2021-12-30 10:31:26 The discussion section is the core part of a SCI paper because it can reflect the breadth and depth of the author's research. Therefore, there is no specified word limit for this section. Depending on the article and the author, the length of the discussion section varies, ranging from a few thousand words to tens of thousands of words ![]() ![]() |
Author: 八坂篷蔚 Subject Area: Medicine Duration of Peer Review: 0.0 month(s) Result: Pending & Unknown Write a review |
Reviewed 2021-12-28 19:23:06 Is the long discussion displaying the author's thoughts on the topic? Does the reviewer have a positive impression of the manuscript? ![]() ![]() |
Author: Darlene Pepys Subject Area: Medicine Duration of Peer Review: 0.0 month(s) Result: Pending & Unknown Write a review |
Reviewed 2021-12-27 10:00:35 What is IF? ![]() ![]() |
First Previous 1 Next Last (To Page |